Table 3.
Symbol | Gene name | YRI vs. CEU | YRI vs. CHB + JPT | CEU vs. CHB + JPT | Biological processes | |||
FST | P | FST | P | FST | P | |||
GRB2 | growth factor receptor-bound protein 2 | 0.720 | 0.035* | 0.828 | 0.023* | 0.048 | 0.556 | Immune response |
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.658 | 0.043* | 0.555 | 0.071 | 0.034 | 0.605 | Immune response |
IL4 | interleukin 4 | 0.262 | 0.220 | 0.205 | 0.329 | 0.512 | 0.043* | Immune response/Apoptosis |
IL6 | interleukin 6 | 0.108 | 0.478 | 0.431 | 0.119 | 0.570 | 0.037* | Immune response/Apoptosis |
ARHGEF1 | Rho guanine nucleotide exchange factor 1 | 0.769 | 0.030* | 0.532 | 0.078 | 0.149 | 0.263 | Apoptosis |
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.642 | 0.045* | 0.544 | 0.074 | 0.070 | 0.456 | Apoptosis |
BCL2L1 | BCL2-like 1 | 0.278 | 0.204 | 0.679 | 0.043* | 0.265 | 0.127 | Apoptosis |
PMVK | phosphomevalonate kinase | 0.563 | 0.059* | 0.652 | 0.048* | 0.097 | 0.380 | Lipoprotein metabolism |
F2 | coagulation factor II | 0.413 | 0.109 | 0.536 | 0.077 | 0.473 | 0.049* | Blood clotting |
* Genes with a significantly higher weighted-average FST